 |
 |

Sudden Cardiac Death and Antipsychotic Drugs
Do We Know Enough?
Arch Gen Psychiatry. 2001;58:1168-1171.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
ANTIPSYCHOTIC drugs have revolutionized the treatment of psychotic and
mood disorders since their introduction 50 years ago. Although psychiatric
patients have significantly benefited from the use of typical antipsychotic
drugs, their limitations have become apparent and include extrapyramidal symptoms
and tardive dyskinesia. The next generation of antipsychotic drugs (novel
or atypical) offers advantages compared with the typical antipsychotic drugs:
they are uniformly better tolerated and are more efficacious in certain symptom
domains. However, current data do not suggest that these new medications offer
advantages regarding cardiovascular adverse effects.1
To ascertain the safety profile of new drugs, phase 2 and phase 3 clinical
trials are conducted and typically involve the study of several hundred patients.
However, rare or idiosyncratic adverse effects missed during phase 2 or 3
trials may become apparent only after the drug is released onto the market.
Sudden death in psychiatric patients treated with antipsychotic drugs has
been . . . [Full Text of this Article]
RELATED ARTICLE
Antipsychotics and the Risk of Sudden Cardiac Death
Wayne A. Ray, Sarah Meredith, Purushottam B. Thapa, Keith G. Meador, Kathi Hall, and Katherine T. Murray
Arch Gen Psychiatry. 2001;58(12):1161-1167.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Association of antipsychotic and antidepressant drugs with Q-T interval prolongation
Zemrak and Kenna
Am J Health Syst Pharm 2008;65:1029-1038.
ABSTRACT
| FULL TEXT
A Systematic Review of the Soteria Paradigm for the Treatment of People Diagnosed With Schizophrenia
Calton et al.
Schizophr Bull 2008;34:181-192.
ABSTRACT
| FULL TEXT
Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data
Hennessy et al.
BMJ 2002;325:1070-1070.
ABSTRACT
| FULL TEXT
Antipsychotics and sudden death: is thioridazine the only bad actor?
RAY and MEADOR
Br. J. Psychiatry 2002;180:483-484.
FULL TEXT
Neuroleptics and Sudden Cardiac Death
JWatch Psychiatry 2002;2002:4-4.
FULL TEXT
|